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Studies of the biology of Borrelia burgdorferi and the pathogenesis of Lyme disease are severely limited by the
current lack of genetic tools. As an initial step toward facile genetic manipulation of this pathogenic spirochete,
we have investigated gene inactivation by allelic exchange using a mutated borrelial gyrB gene that confers
resistance to the antibiotic coumermycin A1 as a selectable marker. We have transformed B. burgdorferi by
electroporation with a linear fragment of DNA in which this selectable marker was flanked by sequences from
a native borrelial 26-kb circular plasmid. We have identified coumermycin A1-resistant transformants in which
gyrB had interrupted the targeted site on the 26-kb plasmid via homologous recombination with the flanking
sequences. Antibiotic resistance conferred by the mutated gyrB gene on the plasmid is dominant, and transformed spirochetes carrying this plasmid do not contain any unaltered copies of the plasmid. Coumermycin A1
resistance can be transferred to naive B. burgdorferi by transformation with borrelial plasmid DNA from the
initial transformants. This work represents the first example of a directed mutation in B. burgdorferi whereby
a large segment of heterologous DNA (gyrB) has been inserted via homologous recombination with flanking
sequences, thus demonstrating the feasibility of specific gene inactivation by allelic exchange.
the infectious cycle or disease requires the ability to genetically
manipulate the spirochete.
We would like to investigate the potential role of genes
located on a 26-kb circular plasmid (cp26) of B. burgdorferi in
environmental sensing and adaptation to the tick vector and
mammalian host. All B. burgdorferi isolates analyzed contain
cp26 (26, 28, 53). Genes carried by cp26 include those encoding the differentially synthesized outer surface protein C
(ospC) (28, 44, 49), the purine biosynthetic enzymes GMP
synthetase (guaA) and IMP dehydrogenase (guaB) (30), and a
homolog of the peptide-binding component of the oligopeptide permease system (oppA) (17a). OspC appears on the surface of spirochetes in ticks following a blood meal but preceding transmission to the mammal (49). GMP synthesis is
probably essential in mammals but not in ticks (30). In other
bacteria, OppA can be a receptor for peptide pheromones that
signal adaptive responses to environmental conditions (22, 27,
34, 39, 40, 55). Given this information, each of these gene
products, and perhaps genes located elsewhere on the 26-kb
plasmid, may play an essential role in the adaptation of B. burgdorferi to either the tick or the mammalian environment or may
facilitate transmission between these two hosts. To study the
functions of these and other genes in B. burgdorferi, we have
undertaken to develop a method for specific gene inactivation.
B. burgdorferi variants that are resistant to the DNA gyrase
inhibitor coumermycin A1 (i.e., are Cour) have been isolated
(48), and the mutations have been mapped to the gyrB gene
(47). With the long-term goal of inactivating specific genes by
allelic replacement, our initial aim was to insert a copy of the
B. burgdorferi gyrB gene that confers Cour (gyrBr) into a noncoding site on cp26. We chose this approach for several reasons. First, to demonstrate the feasibility of the technique, we
wanted to begin with a presumably nonessential site to ensure
that there was no counterselection against the desired insertion. Second, the transformed spirochetes would have both a

Borrelia burgdorferi is maintained in nature through an infectious cycle between wild mammals and ticks (25). Lyme
disease, the most common arthropod-borne disease in the
United States, is acquired when an infected tick feeds upon a
human and transmits B. burgdorferi (8, 20, 52). There are currently very few genetic tools with which to study the biology of
B. burgdorferi and the pathogenesis of Lyme disease. To date,
there are no descriptions of any phage or plasmid vectors that
can be used to efficiently introduce recombinant DNA into
borreliae. Transformation of B. burgdorferi by electroporation
was only recently achieved (47); those experiments provided
definitive evidence for homologous recombination between exogenous DNA introduced by electroporation and related sequences on the chromosome. In these transformations, a segment of a chromosomal gene was replaced by donor DNA that
differed by only a small (2-bp) mismatch.
B. burgdorferi has an unusual genome composed of a linear
chromosome (6, 11, 15, 16) and multiple linear and circular
plasmids (2, 5, 17, 19, 50, 54). It has been proposed that these
various DNA molecules represent components of a segmented
genome and that the distinction between plasmid and chromosome may not be relevant to borreliae (4, 7, 16). Genes encoding a number of different proteins have been cloned and
mapped to the chromosome or plasmids (10, 11, 12, 15). Cellular localization, pattern of expression, and putative function
have been determined for a number of these proteins. However, a definitive understanding of the roles that any of these
gene products or genomic components play in the spirochete,
their essential or dispensable nature, or their significance to
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TABLE 1. Coumermycin A1 sensitivity of gyrB gene
products from strains used in this study
Straina

Chromosomal gyrB

cp26 gyrBb

wt B31
B31-NGR
B31-67
B31-3
B31-9

Sensitive
Resistant
Sensitive
Sensitive
Resistant

—
—
Resistant
Resistant
—

a
wt B31 is the uncloned high-passage-number coumermycin A1-susceptible
strain from which clones B31-NGR, -3, -9, and -67 were derived by transformation. The 50% inhibitory concentration for wt B31 is 0.04 mg of coumermycin A1
per ml (48).
b
—, absence of gyrBr on cp26. Where present, the gyrBr gene is located
between the 39 ends of the oppA and guaB genes.

wild-type (wt) (chromosomal) and mutated (plasmid) copy of
the gyrB gene, which would render them heterozygous for the
B subunit of DNA gyrase and could affect DNA supercoiling
(31). Insertion of gyrB into a noncoding site would serve as a
control for possible pleiotropic effects of altered supercoiling
in subsequent gene inactivation experiments. Finally, we chose
gyrBr, despite this and other potential shortcomings, because it
was the only antibiotic resistance marker for which there were
data demonstrating a selectable phenotype in B. burgdorferi
(47, 48). Previous attempts to transform B. burgdorferi with
other antibiotic resistance markers have been unsuccessful
(56).
In this report, we describe targeted insertion of gyrBr into
cp26. This represents the first demonstration of directed mutation in B. burgdorferi whereby a large segment of heterologous DNA encoding a selectable marker has been inserted via
homologous recombination with flanking sequences, thus demonstrating the feasibility of specific gene inactivation by allelic
exchange.
MATERIALS AND METHODS
Bacterial strains and DNA. B. burgdorferi strains used in this study are listed
in Table 1. Spirochetes were grown in liquid BSK-H medium (Sigma, St. Louis,
Mo.) at 348C (1). The protocol for plating B. burgdorferi in solid medium (24) was
modified as follows: spirochetes were plated within a layer of top agarose rather
than on the surface, and plates were incubated at 358C in a humidified 1% CO2
tissue culture incubator rather than in a candle jar (35, 36). wt B31 (ATCC
35210) is a high-passage-number, noninfectious, uncloned B. burgdorferi sensu
strictu prototype strain, originally isolated from a tick collected on Shelter Island,
N.Y. (8). Cour clone B31-NGR was derived from wt B31 by transformation and
contains the following mutations in gyrB that together confer high-level Cour:
asparagine 102 to aspartate (N102D), glycine 104 to aspartate (G104D), and
arginine 133 to isoleucine (R133I) (46a). The donor DNA containing these
mutations was created by PCR with overlapping primers that encoded the
N102D and G104D mutations, using DNA from an R133I Cour transformant
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(47) as the template. Cour clones B31-3, -67, and -9 were derived from wt B31 by
transformation with recombinant plasmid pKK58 (described below), which contains a copy of the gyrBr gene from B31-NGR.
Cloning. The gyrBr gene of B31-NGR was amplified by PCR (32, 45) with
primers U178F1BglII and 1905R1BclI (Table 2). This fragment extends from
178 nucleotides upstream of the gyrB start codon to the stop codon at the end of
the gene; the 59 end of this fragment is 11 nucleotides from the first codon of the
divergently transcribed dnaA gene as described by Saint Girons et al. (45a)
(corresponding to nucleotide 1320 of GenBank accession number U04527) and
presumably includes the gyrB promoter. This fragment was digested with restriction enzymes BglII and BclI and ligated into BglII-digested clone pDH63, a
genomic clone isolated from a B. burgdorferi B31 DNA library constructed in
Lambda ZapII (Stratagene, La Jolla, Calif.) (30), whose 3.5-kb insert is derived
from cp26 and spans the oppA and guaB genes (17a). The resulting plasmid,
pKK58, which contains a complete copy of gyrBr inserted between the 39 ends of
oppA and guaB, is diagrammed in Fig. 1A. There are approximately 1.75 and 1.4
kb of cp26 sequence flanking the 59 and 39 ends, respectively, of gyrBr. pKK58 was
digested with PvuI to inactivate the ampicillin resistance gene before transformation into B. burgdorferi. Restriction enzymes were obtained from New England Biolabs (Beverly, Mass.) and used according to the supplier’s recommendations.
Transformation. Preparation of competent borreliae, electroporation, and
plating of spirochetes were done as previously described (46, 47), with the
following modifications: after electroporation and 24-h incubation in liquid medium without antibiotic, spirochetes were plated in the presence of 0.5 mg of
coumermycin A1 (Sigma) per ml and incubated at 358C in a humidified 1% CO2
environment. All electroporations were done with equivalent aliquots of the
same preparation of frozen, competent B. burgdorferi and 1 mg of DNA. The final
volume of the transformed culture was 10 ml and contained approximately 108
bacteria per ml at the time of plating. DNA for electroporation was resuspended
in distilled water at a concentration of approximately 1 mg/ml, and 1 m1 (1 mg)
was used per electroporation. Colonies began to appear 5 to 7 days after plating;
the total number of colonies was determined approximately 14 days after plating.
The transformation frequency represents the total number of Cour colonies per
mg of donor DNA per 109 viable bacteria following electroporation. We note that
neither the DNA nor the competent bacteria are in excess under these transformation conditions; increasing either of these components in the electroporation
results in more Cour transformants. The amount of the culture plated varied with
experiments but was generally 0.01 to 0.5 ml per plate. We found significant
inhibition of colony formation when more than 1 ml of the 10-ml transformed
culture was used per plate (the medium turned yellow with time, indicative of
bacterial growth, but individual colonies were not visible). We believe that this
difference from the previous transformation and plating results, in which the
entire transformed culture was concentrated and plated (47), is probably due
to the fact that our competent bacteria were prepared from a denser culture,
which resulted in more bacteria per aliquot. This is also consistent with obtaining approximately 10-fold more transformants per microgram of DNA than in
previous experiments. We did not note a decrease in the ability to transform
B. burgdorferi with increasing density of the initial culture from which the competent bacteria were prepared.
PCR. Oligonucleotide primers used for PCR are described in Table 2 and
specified in individual experiments. PCR-amplified fragments used in cloning
and transformation and as probes were produced in a TC1 DNA Thermal Cycler
(Perkin Elmer/Applied Biosystems, Foster City, Calif.); PCR conditions for
fragment production were 25 cycles of 948C for 1 min, 508C for 0.5 min, and 708C
for 3 min, with 100 ng of total genomic DNA as the template. Fragments were
amplified through two rounds of PCR, with a 1:100 dilution of the first reaction,
of which 1 ml was used in the second reaction to minimize carryover of the
template genomic DNA in the final PCR product. Fragments were purified by
ammonium acetate-isopropanol precipitation. PCR screening of Cour B. burg-

TABLE 2. Oligonucleotide primers used in this study
Primer
No.a

Designation

1
2
3
4
5
6
7
8
9
10

gb.18
gb.33
gb.45
pc.42
1696F
246R
U178F1BglII
1905R1BclI
24R
IIR

a

Sequence (59 3 39)

Gene

GCAATAATAATTGAAAGAGATT
CAAATTAAATAACTAACATC
TAGATCATTGCAAACAAT
GGACTGAACTTCCTTACAGT
CTTCAGAGATATAAAGGGCTTGGG
CTCTTCATGAATATCGGTAGG
ACCAGATCTTGTTGGTTTTAGCACTATA
ACCTTGATCATTACACATCAAGATTAATTAC
CCATATATTTTTTGATTTTTCCAT
AATCCTTACTGGATTCAAGAG

oppA
guaB
59-oppA
guaA
gyrB
gyrB
59-gyrB
gyrB
dnaA
gyrA

The relative positions and orientations of primers in chromosomal or cp26 genes are indicated by these numbers in Fig. 3A.
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FIG. 1. pKK58 and the 26-kb circular plasmid of B. burgdorferi. (A) The positions of relevant restriction sites and genes on pKK58 and the extent of the cp26
genomic fragment with the gyrBr insertion are as indicated. (B) The positions of relevant restriction sites and genes on cp26 and the site of the targeted gyrBr insertion
are as indicated. Arrows beneath genes point in the direction of transcription.

dorferi colonies was done in a 9600 DNA Thermal Cycler (Perkin Elmer/Applied
Biosystems). Reaction volume was 20 ml per sample, and PCR conditions were
30 cycles of 948C for 0.5 min, 508C for 0.5 min, and 688C for 2 min. Individual
B. burgdorferi colonies were picked with sterile toothpicks directly to tubes with
PCR mix. There was no additional boiling or lysis step before PCR amplification.
PCR products were analyzed by agarose gel electrophoresis and visualized with
ethidium bromide. Cour colonies identified by PCR as having a gyrBr insertion on
cp26 were subcultured in liquid medium.
Southern blots. Total genomic DNA was isolated from B. burgdorferi as previously described (37). Total plasmid DNA, including both linear and circular
molecules, was isolated from B. burgdorferi with Qiagen (Chatsworth, Calif.)
columns as instructed by the manufacturer. The plasmid content of Qiagen
column-purified borrelial DNA is similar to that of total genomic DNA, whereas
chromosomal DNA is undetectable (34a). Southern blot analyses (51) were
performed with the following electrophoretic conditions: DNA was separated on
a 0.8% agarose gel by field inversion electrophoresis for 24 h at 7 V/cm with
program 3 of a PPI-200 programmable power inverter (the forward pulse ranges
between 0.15 and 4.803 s, the reverse pulse ranges between 0.05 and 1.601 s, and
one complete cycle takes 2 min 3.9 s) (MJ Research, Watertown, Mass.). DNA
was transferred bidirectionally to Biotrans nylon membranes (ICN, Irvine, Calif.)
and hybridized with a radiolabeled probe at 558C in rotating bottles in a hybridization oven (Bellco, Vineland, N.J.) (37). Probe fragments were generated by
PCR amplification, and the purified PCR products were radiolabeled with
[a-32P]dATP (Du Pont, Boston, Mass.) by random priming (Life Technologies,
Gaithersburg, Md.).

bacteria were Cour following transformation with 1 mg of linearized pKK58 DNA. Spontaneous resistance arose at a frequency of about 5 in 108 bacteria. Colonies were screened for
targeted insertion on cp26 by PCR (Fig. 2), using opposing

RESULTS
Construction of a gyrBr/cp26 DNA fragment for allelic exchange. To generate a DNA fragment for pilot gene inactivation experiments, the complete gyrBr gene, including the promoter, of Cour B. burgdorferi clone B31-NGR was amplified by
PCR and inserted into a previously cloned fragment that
spanned the oppA and guaB genes from cp26. The gyrBr gene
was cloned into the intergenic region between the 39 ends of
the converging genes; the resulting recombinant, pKK58, has
greater than 1 kb of cp26 sequence flanking either side of gyrBr
(Fig. 1A). A linearized version of this plasmid, in which the
gene conferring ampicillin resistance was inactivated by digestion with PvuI, was the DNA fragment used in the initial
transformations. The relative positions on cp26 of oppA, guaB,
guaA, ospC, and the targeted insertion site for gyrBr are shown
in Fig. 1B.
Screening of Cour transformants by PCR analysis. B. burgdorferi B31 was transformed by electroporation with linearized
pKK58. Sham electroporations without DNA, or in which
DNA was added after electroporation, were done to control
for spontaneous Cour B. burgdorferi. Approximately 1 in 105

FIG. 2. Screening Cour transformants for gyrBr insertion on cp26 following
electroporation with pKK58 DNA. Individual B. burgdorferi colonies were PCR
amplified with primers 1 and 2 (Table 2 and Fig. 3A). PCR products from 96
samples were analyzed by agarose gel electrophoresis and visualized with
ethidium bromide. The positions of the sample wells (four sets) are indicated on
the left. The first and last samples in each row are size standards. Open and
closed arrows on the right indicate the mobilities of the cp26 PCR fragment with
and without the gyrBr insertion, respectively. Control samples amplified at the
same time as the colonies were pKK58 (lane 1), wt B31 (lane 2), a blank spot on
the plate (lane 3), and the reagent blank (lane 4).

VOL. 178, 1996

FIG. 3. Confirmation of gyrBr insertion on cp26 in Cour transformants. (A)
The locations and orientations of primers on B. burgdorferi (Bb) cp26 and
chromosomal genes are as indicated. Individual primer sequences are given in
Table 2. The extent of cloned cp26 DNA and the position of the gyrBr insertion
in E. coli (Ec) plasmid pKK58 are as shown. (B) wt B31 (lanes a), transformant
B31-67 (lanes b), and pKK58 (lanes c) DNA preparations were PCR amplified
with primer pairs indicated above the lanes, separated by agarose gel electrophoresis, and visualized with ethidium bromide. The mobilities of size standards
are indicated at the sides.

primers in the oppA and guaB genes (primers 1 and 2 [Fig.
3A]); the primer-binding sites were also present in the pKK58
DNA fragment that was used in the transformation.
Depending on where the donor DNA fragment recombined,
at least three different classes of Cour transformants should be
identifiable by PCR with these primers: (i) the desired event,
homologous recombination with flanking cp26 sequences,
would generate a single PCR fragment that is approximately 2
kb larger than the wt cp26 fragment as a result of the insertion
of gyrBr; (ii) homologous recombination between gyrBr sequences on pKK58 DNA and the chromosomal gyrB gene
would leave only a wt PCR target on cp26; and (iii) illegitimate
recombination at a nonhomologous site would give rise to
two PCR fragments, one from the unaltered cp26 locus and
a second, larger fragment from the pKK58 insertion elsewhere.
The results of one such experiment are shown in Fig. 2.
Ninety-two colonies were tested by PCR; 91 colonies had a
PCR fragment that was the same size as the wt fragment from
untransformed spirochetes, and one colony had a PCR fragment that was consistent with the insertion of gyrBr on cp26.
No amplified products were obtained when a blank spot on the
plate instead of a colony was picked (Fig. 2, lane 3, controls),
indicating that neither the DNA used in the electroporation
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nor that of coumermycin A1-susceptible dead bacteria gave
rise to the amplified fragments. In total, 2 of 461 (0.4%) of the
Cour colonies screened in this experiment appeared to have
gyrBr inserted at the targeted site on cp26. The other 459
colonies had a PCR fragment identical to the wt cp26 locus;
these represent transformants in which the donor DNA recombined via gyrB sequences at the chromosomal locus rather than
via flanking oppA and guaB sequences on cp26. There were no
Cour clones with both PCR fragments, suggesting that illegitimate recombination of the transforming DNA into a nonhomologous site in the genome is rare.
Confirmation of gyrBr insertion on cp26 by PCR and Southern blot analysis. To verify the insertion of gyrBr on cp26 in
candidate transformants, we used PCR primers within gyrB in
combination with various primers in oppA and guaB. The approximate locations of these cp26 and gyrB primers are shown
in Fig. 3A. The results with five primer pairs and three template DNA preparations (wt B31, transformant clone B31-67,
and plasmid pKK58) are shown in Fig. 3B. Amplification products between all gyrB and cp26 primers (primer pairs 1-6, 3-6,
5-2, and 5-4) were obtained with B31-67 DNA (lanes b). No
amplified products were obtained with these primers and wt
B31 DNA (lanes a). No amplification products were obtained
with pKK58 plasmid DNA when distal cp26 primers outside
the cloned segment were used with gyrB primers (primer pairs
3-6 and 5-4 [lanes c]). These data are entirely consistent with
the targeted insertion of gyrB between guaB and oppA on cp26
in B31-67. Identical results were obtained with transformant
B31-3 (data not shown).
We did Southern blot analyses to directly demonstrate the
presence of gyrBr on cp26, adjacent to guaB, in those transformants that appeared to have a targeted insertion. Previous
sequence analyses had identified a BamHI site in guaA (30);
mapping studies indicated that this was the only BamHI site on
cp26 (9a). The B31 chromosomal gyrB locus also contains a
single BamHI site (46b). Figure 1B shows the anticipated positions of the BamHI sites and genes on cp26 relative to the
gyrBr insertion. Duplicate blots, hybridized with either a guaB
or a gyrB probe, were made from a field inversion gel on which
were electrophoresed uncut and BamHI-digested DNA preparations from representative Cour transformants, one in which
gyrBr was inserted into cp26 (B31-3) and one in which gyrBr
recombined with the chromosomal gyrB gene (B31-9) (Fig. 4).
Digestion of B31-9 DNA with BamHI yielded a large (approximately 26-kb) fragment that hybridized with the guaB
probe (Fig. 4, lane 9, cut), consistent with the presence of a
single BamHI site in cp26. Insertion of gyrBr adjacent to guaB
in clone B31-3 introduced another BamHI site and consequently yielded a much smaller (approximately 3-kb) fragment
that hybridized with the guaB probe (lane 3, cut). Hybridization of the gyrB probe to uncut cp26 from clone B31-3 confirmed that gyrBr is present on the plasmid in B31-3 (lane 3,
uncut) and linked with guaB on the 3-kb BamHI fragment
(lane 3, cut). Circular plasmids are retarded and not well resolved, relative to linear DNA, under these field inversion
electrophoresis conditions (54); therefore, uncut DNA yields
multiple slowly migrating cp26 bands that hybridize to the
guaB probe (lanes 3 and 9, uncut). As shown in Fig. 4, we have
noted an unanticipated but consistent difference in the mobility of uncut cp26 between B31-3 and B31-9, possibly reflecting
a difference in DNA supercoiling. As predicted, clones B31-3
and B31-9 each contain a chromosomal gyrB allele, and the
BamHI fragment from this gene was the same size (approximately 50 kb) in both clones. Similar results were obtained by
Southern analysis of clone B31-67 (data not shown). We conclude that Cour transformants B31-3 and B31-67 contain gyrBr
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FIG. 4. Southern blot analysis of Cour transformants. Uncut and BamHIdigested DNA preparations from transformants B31-3 (lanes 3) and B31-9 (lanes
9) were separated by field inversion gel electrophoresis, transferred to membranes, hybridized to either guaB or gyrB radiolabeled probes, and visualized by
autoradiography. The source of the DNA and whether it was uncut or BamHIdigested (cut) are indicated above each lane; the probe with which each blot was
hybridized is indicated at the top. The lanes showing BamHI-digested DNA
hybridized with a gyrB probe are a shorter exposure of the same blot as undigested DNA. The mobilities of size standards are indicated at the left side. The
gyrB probe spanned the entire gene and was the same fragment that was inserted
into cp26 (amplified with primers 7 and 8 [Table 2]). The guaB probe fragment
spanned nucleotides 290 to 512 of the gene (30).

at the targeted site on cp26 in addition to the gyrB gene at the
wt chromosomal locus. There was no evidence for insertion of
gyrBr at any other site in these bacteria or for any chromosomal
or plasmid rearrangement.
Analysis of chromosomal and cp26 gyrB alleles. Although
we anticipated that the DNA introduced by electroporation
could generate Cour B. burgdorferi by recombination with homologous sequences on either cp26 or the chromosome, most
(459 of 461) of the transformants resulted from recombination
with the chromosomal gyrB gene. One possible explanation for
this finding is that the gyrBr allele on cp26 does not confer
Cour, and those rare transformants with gyrBr inserted on the
plasmid must also have a gyrB allele conferring Cour at the
chromosomal locus. Another possibility is that the normal gyrB
promoter is not efficiently transcribed on cp26, perhaps because of differences in DNA supercoiling or topology between
the linear chromosome and a circular plasmid, and the plasmid
gyrBr gene must acquire some additional mutation for adequate expression at this site. To address these possibilities, the
gyrB genes from both loci of transformant B31-3 were amplified with primers in flanking sequences and the PCR fragments
were subjected to partial sequence analysis. These studies indicated that the promoter region and residues critical for Cour
of the cp26 gyrBr allele of B31-3 were identical in sequence to
the B31-NGR gyrBr DNA with which it was transformed and
that the chromosomal gyrB allele of B31-3 was wt at those
residues that are mutated in B31-NGR or other Cour B. burgdorferi strains (not shown).
To directly test the ability of the cp26 gyrB allele of B31-3 to
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confer Cour, the PCR fragments described above were used to
transform B. burgdorferi by electroporation and the number of
Cour transformants was determined by plating (Table 3). The
chromosomal gyrBr genes from B31-NGR and B31-9 were amplified as positive controls, and the unaltered cp26 site from
B31-9 (in which there was no gyrBr insertion) was amplified as
a negative control. The transformation frequency following
electroporation of DNA from the cp26 gyrBr allele of B31-3
(1025) was comparable to the transformation frequencies with
DNA from the chromosomal gyrBr genes of B31-9 (3 3 1026)
and B31-NGR (6 3 1026). The transformation frequency following electroporation of DNA from the chromosomal gyrB
allele of B31-3 was the same as the background level of spontaneous Cour (9 3 1028), approximately 100-fold less than that
of the cp26 gyrBr allele. We conclude that the gyrBr insertions
on cp26 confer Cour, that no additional mutations were necessary for adequate gene expression at this site, and that some
other factor dictated the low frequency of integration at this
site.
The transformations described in Table 3 were done with a
cp26 gyrBr fragment that contained very little cp26 flanking
sequence (166 nucleotides 59 and 244 nucleotides 39). We
repeated this experiment with more distal cp26 primers, located approximately 1 kb away on either side of the gyrBr
insertion, to amplify cp26 fragments from B31-3 and B31-9. In
this experiment, the transformation frequency was 2 3 1025/
mg of the B31-3 cp26 gyrBr fragment, compared with a spontaneous Cour frequency of less than 1027 (B31-9 cp26 fragment, lacking gyrBr). PCR screening of 89 Cour transformants
obtained with the B31-3 cp26 gyrBr fragment indicated that all
had recombined into the chromosomal gyrB locus. Therefore,
even when gyrBr was derived from cp26, it still preferentially
recombined into the chromosomal locus. This result again indicated that the low frequency of gyrBr insertion on cp26 following transformation with pKK58 DNA was not due to the
need to acquire additional mutations that allow a dominant
phenotype and adequate expression of gyrBr on cp26.
Transformation of B. burgdorferi with borrelial plasmid
DNA. We wished to determine if cp26 containing gyrBr could
be used to transform wt spirochetes to a resistant phenotype,

TABLE 3. Transformation with PCR fragments amplified
from the chromosomal or cp26 gyrB alleles
a

b

DNA

gyrB locus

B31-3
B31-3
B31-9
B31-9
B31-NGR

Chromosome
cp26
Chromosome
cp26e
Chromosome

No. of Cour
coloniesc
0.01 ml

0.1 ml

0, 0
14, 13
1, 3
0, 0
9, 3

0, 2
106, 95
40, 22
0, 2
68, 59

Transformation
frequencyd

9.0 3 1028
1.0 3 1025
3.0 3 1026
9.0 3 1028
6.3 3 1026

a
The source of genomic DNA used in the PCR to generate a fragment for
transformation.
b
Locus from which the gyrB allele was amplified. Primers for the chromosomal
locus were 9 and 10, and primers for cp26 were 1 and 2 (Fig. 3A and Table 2).
c
The final volume of each transformation was 10 ml. Of this, 0.01 and 0.1 ml
were plated in duplicate from a single transformation, and the number of Cour
colonies per plate is given.
d
Fraction of viable bacteria in the transformation that are Cour per microgram of donor DNA. All transformations were done with 1 mg of DNA and
contained approximately 109 viable bacteria at the time of plating. This figure
was calculated by multiplying the total number of Cour colonies obtained per
volume plated (0.22 ml) by the appropriate factor (45.5) to account for the total
volume (10 ml) of the transformation mix and dividing by 109.
e
B31-9 does not contain gyrBr on cp26. The PCR fragment obtained with
primers 1 and 2 from B31-9 was used as a control for spontaneous Cour.
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TABLE 4. Transformation with borrelial plasmid DNA
Expt

I

II

Plasmid
DNAa

B31-3
B31-67
B31-9
B31-67, uncut
B31-67, cut
with BglIf
No DNA

No. of Cour coloniesb
0.1 ml

0.5 ml

1.0 ml

3
1
0

11
8
NDe
5, 4, 5, 6
27, 37, 27

17
10
9

5, 2, 7, 5

gyrBr on
cp26c

Transformation
frequencyd

1/31
2/19
ND
1/20
16/80

1.9 3 1027
1.2 3 1027
5.6 3 1028
1.0 3 1027
6.0 3 1027

ND

1.0 3 1027

a

Plasmid DNA isolated from B. burgdorferi by using Qiagen columns included
all linear and circular plasmids. B31-9 cp26 does not contain gyrBr and thus
represents a control for spontaneous Cour.
b
The final volume of each electroporation was 10 ml. Of this, the indicated
volume was plated, and the number of Cour colonies per plate is given.
c
Colonies were screened for gyrBr insertion on cp26 by PCR with primers 1
and 2, as indicated in Fig. 3A. The fraction given represents the number of
colonies positive for gyrBr on cp26 per total number of colonies screened.
d
Fraction of viable bacteria in the transformation that are Cour per microgram of donor DNA.
e
ND, not done.
f
Plasmid DNA from B31-67 was digested with BglI before electroporation.
Not all Cour colonies were screened by PCR.

either by displacing the resident cp26 or by recombining with
it. Transformation with borrelial plasmid DNA would differ
from previous experiments in several ways that could potentially influence the uptake, degradation, and recombination of
donor DNA. First, cp26, as a supercoiled circular plasmid,
represents a different physical form of DNA than linear pKK58
or PCR fragments. Second, native cp26 would contain borrelial
DNA modifications that would not be present on Escherichia
coli DNA or PCR fragments. Finally, there is much more cp26
sequence flanking gyrBr on the intact plasmid than there was
on pKK58.
When total plasmid DNA preparations from Cour transformants B31-3 and B31-67 were transformed by electroporation
back into wt B. burgdorferi, the frequencies of Cour colonies
following transformation (1.9 3 1027 and 1.3 3 1027, respectively) were only slightly greater than that of spontaneous resistance in the negative control (5.6 3 1028; B31-9) (Table 4,
experiment I). This reduction in transformation frequency,
relative to the original experiments, could be explained largely
by the difference in complexity between total plasmid DNA
and the PCR fragments (approximately 2.5 3 105 and 5 3 103
bp, respectively) and the corresponding molarity of gyrBr sequences present in 1 mg of DNA used in the transformations.
All the same, PCR screening indicated that 3 of 50 Cour
colonies following transformation with B31-3 and B31-67 plasmid DNA had gyrBr on cp26 (Table 4, experiment I). Sequence
analysis of the chromosomal gyrB locus from 10 Cour colonies
from this transformation that did not have a gyrB insertion on
cp26 indicated that 5 were transformants and 5 were spontaneous Cour mutants. Since approximately half of the Cour
colonies with B31-3 plasmid DNA were spontaneous mutants,
gyrBr insertion on cp26 probably occurred in more than 10% of
the actual transformants in this experiment. We conclude that
the overall transformation efficiency was not increased with
borrelial plasmid DNA relative to linear PCR fragments or
E. coli plasmid fragments, but that a larger fraction of the
transformants had gyrBr at the targeted site on cp26.
In the previous experiment, transformants carrying gyrBr on
cp26 could have arisen by recombination between donor and
resident plasmids or by displacement of resident cp26 by donor
plasmid. We reasoned that linearizing cp26 in the donor DNA
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should reduce the number of transformants with gyrBr on cp26
if the donor plasmid was displacing the resident plasmid, because a second event, religation, would be necessary to stably
maintain the transforming plasmid DNA. Conversely, if transformants containing gyrBr on cp26 arose by recombination
between donor and resident plasmids, linearizing cp26 might
stimulate this event because a discontinuity would already exist
in the transforming DNA. We subsequently compared transformation efficiencies of uncut and linearized total plasmid
DNA from B31-67. Mapping studies of cp26 have demonstrated a single BglI site, approximately 13 kb away in both
directions from the gyrBr insertion site (Fig. 1B) (9a). Transformation with BglI-digested plasmid DNA resulted in approximately sixfold more Cour colonies than with uncut plasmid per
microgram of DNA (6 3 1027, and 1 3 1027, respectively)
(Table 4, experiment II). Again, the frequency of Cour transformants following electroporation with uncut plasmid DNA
was not different from that of spontaneous Cour colonies in the
sham electroporation without DNA (1027). PCR screening of
the transformants demonstrated the presence of gyrBr on cp26
in 16 of 80 (20%) of the Cour colonies following electroporation with BglI-digested plasmid DNA (Table 4, experiment II).
Since the overall frequency of transformation was increased
with linearized cp26 and the fraction of transformants with
gyrBr on cp26 did not decrease, this experiment suggests that
recombination between donor DNA and resident cp26, rather
than displacement of the wt plasmid, probably generated the
Cour transformants carrying gyrBr on cp26 in these experiments with borrelial plasmid DNA.
DISCUSSION
We have carried out important steps toward the goal of gene
inactivation by allelic exchange in B. burgdorferi, using as a
selectable marker a mutated borrelial gyrB gene that confers
Cour. For this strategy to work, gyrBr must confer a dominant
phenotype because the wt (coumermycin A1-susceptible) gyrB
gene will still be present on the chromosome. Although gyrBr is
a dominant mutation in other bacteria (31), our initial transformation results were not entirely convincing that this was
true in B. burgdorferi: only 0.4% of the Cour colonies following
electroporation with linearized pKK58 DNA were generated
by targeted insertion of gyrBr on cp26. However, the frequency
of gyrBr insertion on cp26 (4 3 1028) was still much greater
than what would be anticipated for two independent events, in
which transforming DNA recombined at both chromosomal
and cp26 sites (10210). Subsequent experiments demonstrated
that Cour borreliae with the gyrBr allele inserted on cp26 were
heterozygous for the gyrB alleles, with a wt copy of the gene on
the chromosome (Table 3). Therefore, gyrBr is dominant and
can be used as a selectable marker for gene inactivation in
B. burgdorferi. We conclude, however, that some aspect of the
transformation with pKK58 DNA favored recombination at
the chromosomal gyrB locus rather than via cp26 sequences. A
strong possibility is that the amount of cp26 flanking sequence
in pKK58 (1.75 kb 59 and 1.4 kb 39 of gyrBr) was insufficient to
efficiently mediate homologous recombination on either side
of a 2-kb segment of heterologous DNA (gyrBr). There is
precedent in other transformation systems for preferential incorporation of small mismatches rather than large regions of
heterologous sequences (33). It is also possible that the biochemistry of homologous recombination with the linear donor
DNA is different if the substrate is a supercoiled plasmid
rather than the linear chromosome. In E. coli, homologous
recombination with plasmids can be mediated by a RecAindependent pathway (23). In addition, targeted insertion of
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gyrBr into cp26 requires a double crossover, whereas recombination into gyrB on the chromosome could occur by gene
conversion (requiring only homologous pairing spanning the
mutation and mismatch repair), which might be more frequent.
When uncut, total borrelial plasmid DNA from a Cour transformant with gyrBr inserted on cp26 was transformed back into
coumermycin A1-susceptible borreliae, the transformation frequency per microgram of DNA was comparable to the level of
spontaneous Cour (Table 4, experiment I). Transformation
with total borrelial plasmid DNA that had been digested with
BglI, which linearizes cp26, increased the transformation frequency about sixfold over the uncut plasmid level (Table 4,
experiment II); approximately 20% of these Cour colonies
carried cp26 with gyrBr. These experiments indicate that Cour
transformants with gyrB on cp26 are generated at a 50-foldhigher frequency with linearized cp26 plasmid DNA than with
the smaller linear pKK58 DNA fragments used in the initial
transformation experiments (20% versus 0.4%). This finding is
consistent with the interpretation that increasing the amount
of cp26 flanking sequence on either side of gyrB (approximately 13 kb versus 1.5 kb) facilitated homologous recombination
with cp26. Additional experiments are necessary to determine
what stimulates recombination at the targeted site relative to
the chromosomal gyrB locus. A different selectable marker that
did not have a wt borrelial counterpart would obviously circumvent this problem. We are currently investigating the utility
of a gene conferring chloramphenicol resistance (18), which
has been used for gene inactivation by allelic exchange in the
spirochete Serpulina hyodysenteriae (38). We are also simplifying our screen for targeted insertion of gyrBr by incorporating
a gene encoding a fluorescent marker between gyrBr and flanking sequences.
In the previous experiments with uncut borrelial plasmid
DNA, Cour colonies containing gyrBr on the plasmid could
have arisen either from stable maintenance of cp26 DNA that
was introduced by electroporation, following segregation of wt
cp26, or from recombination between the transforming DNA
and the resident cp26. We cannot determine which occurred
because gyrBr is the only marker that distinguishes the transforming and the resident forms of cp26. It is not known if
borreliae exhibit plasmid incompatibility such that stable maintenance of a plasmid introduced by transformation would be
inhibited by a homologous resident plasmid. These experiments point out one difficulty in attempting transformation
with cp26 and investigating its potential utility as a borrelial
plasmid vector: all B. burgdorferi isolates analyzed contain cp26
(26, 28, 53). However, cp26 containing gyrB as a selectable
marker might be used to transform other members of the
genus, such as B. hermsii. Although B. hermsii contains a number of circular plasmids, it does not appear to have one that is
closely related to cp26; guaA, guaB, oppA, and ospC homologs
are present on linear plasmids or the chromosome in B. hermsii
(9, 29, 30) (34a). Conversely, a good approach to developing a
plasmid vector for B. burgdorferi may be to introduce a selectable marker such as gyrBr into a B. hermsii plasmid. Alternatively, we have identified a family of related 32-kb circular
plasmids in B. burgdorferi that can coexist within the same
spirochete but are not present in all infectious clones (54). One
of these plasmids may represent a more useful plasmid vector
for B. burgdorferi.
A potential problem in inactivating borrelial genes, either
chromosomal or plasmid borne, is the inherent polyploidy of
the genome: Kitten and Barbour have demonstrated that both
the chromosome and the plasmids of B. hermsii are present at
8 to 16 copies per spirochete (21). Theoretically, heterozygotes
should be generated by transformation in which the selectable
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marker had interrupted only some copies of the gene. However, we never found any examples of heterozygosity (with
reference to cp26) following transformation with pKK58 or
borrelial plasmid DNA. Therefore, the mechanisms of plasmid
replication and segregation in borreliae must ensure homozygosity by the time a single spirochete has replicated to form a
detectable colony. In vivo, B. hermsii must deal with this same
problem in order to derive a clonal advantage from Vmp
antigenic variation (3, 21), whereby the expressed vmp gene,
present on a multicopy plasmid, is replaced with a copy of a
previously silent vmp gene. B. hermsii must either suppress
expression from some copies of this plasmid or coexpress
Vmps from switched and unswitched plasmids until plasmid
homozygosity is attained by segregation.
In this report, we demonstrated targeted insertion of an
antibiotic resistance marker into a circular plasmid of B. burgdorferi via homologous recombination with flanking sequences.
This is the first example in borreliae of a nonspontaneous
mutation whereby the altered or inactivated targeted sequence
does not by itself confer an intrinsic selectable advantage.
Previously, B. burgdorferi variants have been selected by treatment with specific antisera that permitted only growth of escape mutants lacking particular outer surface proteins (13, 14,
41, 42, 43, 44). Similarly, gyrB mutants were selected by the
ability to grow in the presence of coumermycin A1 (47, 48).
Such direct approaches to isolating specific mutations are powerful but restricted to a limited number of genes. The study
presented in this report is an important step toward developing
a convenient means of allelic exchange in B. burgdorferi with
which to inactivate most genes. We are currently using gyrBr to
inactivate genes of interest on cp26 in order to study their roles
in the infectious cycle of B. burgdorferi between ticks and mammals.
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